侵袭性真菌感染治疗新进展

被引:43
作者
李梦
廖万清
机构
[1] 第二军医大学附属长征医院病原真菌分子生物学研究所
关键词
侵袭性真菌感染; 流行病学; 抗真菌药; 治疗;
D O I
暂无
中图分类号
R519 [真菌与放线菌传染病];
学科分类号
100201 [内科学];
摘要
随着免疫受损人群的增多,近年来侵袭性真菌感染的发生率逐渐升高,由此导致的致病率也逐年上升。如何及时诊断并有效的治疗侵袭性真菌感染已成为临床上面临的挑战之一。该文就侵袭性真菌感染的流行病学、病因学及现有的治疗策略等方面进行综述。
引用
收藏
页码:47 / 51
页数:5
相关论文
共 8 条
[2]
Pharmacoeconomics—an aid to better decision-making..Arenas-Guzman R;Tosti A;Hay R; et al;.J Eur Acad Dermatol Venereol.2005, 01
[3]
Comparative survival and cost of antifungal therapy: posaconazole versus standard antifungals in the treatment of refractory invasive aspergillosis [J].
Herbrecht, Raoul ;
Rajagopalan, Srinivasan ;
Danna, Robert ;
Papadopoulos, George .
CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (10) :2457-2464
[4]
Pharmacoeconomics of voriconazole [J].
Rubio-Terres, Carlos ;
Grau, Santiago .
EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (06) :877-887
[5]
Efficacy and safety of caspofungin in solid organ transplant recipients [J].
Petrovic, J. ;
Ngai, A. ;
Bradshaw, S. ;
Williams-Diaz, A. ;
Taylor, A. ;
Sable, C. ;
Vuocolo, S. ;
Kartsonis, N. .
TRANSPLANTATION PROCEEDINGS, 2007, 39 (10) :3117-3120
[6]
Pharmacoeconomics of antifungal pharmacotherapy – challenges and future directions.[J].Johnson;Kleinberg;Danziger;Ostrosky-Zeichner.Expert Opinion on Pharmacotherapy.2005, 15
[7]
Antifungal agents: In vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy [J].
Groll, AH ;
Kolve, H .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2004, 23 (04) :256-270
[8]
Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis [J].
Becker, MJ ;
Lugtenburg, EJ ;
Cornelissen, JJ ;
van der Schee, C ;
Hoogsteden, HC ;
de Marie, S .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (03) :448-457